Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DHAR, MATASHA | 1 | 43.8% | +47.5% |
| BARRON, SEAN C | 1 | 53.3% | +30.6% |
| ARIETI, RUTH SOPHIA | 1 | 45.3% | +72.1% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +17.9% |
| MCCORMICK, CATHERINE LYNN | 1 | 48.8% | +35.6% |
| LEONARD, ARTHUR S | 1 | 50.9% | +50.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18484970 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | ARIETI, RUTH SOPHIA | 24d overdue |
| 18562148 | PRODUCTION OF RECOMBINANT AAV VECTORS FOR TREATING MUSCULAR DYSTROPHY | BARRON, SEAN C | — |
| 18181271 | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18022059 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | MCCORMICK, CATHERINE LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18484970 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | ARIETI, RUTH SOPHIA | 24d overdue |
| 18680380 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | DHAR, MATASHA | — |
| 18562148 | PRODUCTION OF RECOMBINANT AAV VECTORS FOR TREATING MUSCULAR DYSTROPHY | BARRON, SEAN C | — |
| 18181271 | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | POLIAKOVA-GEORGAN, EKATERINA | — |
| 18022059 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | MCCORMICK, CATHERINE LYNN | — |
| 17785879 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | LEONARD, ARTHUR S | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1635 | 1 |
| 1637 | 1 |
| 1638 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18680380 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | DHAR, MATASHA | — | §112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18562148 | PRODUCTION OF RECOMBINANT AAV VECTORS FOR TREATING MUSCULAR DYSTROPHY | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18484970 | EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY | ARIETI, RUTH SOPHIA | 1635 | §103§112 | Final Rejection | 24d overdue | Pending | Oct 11, 2023 |
| 18181271 | EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §101§103DPOther | Non-Final OA | — | Pending | Mar 09, 2023 |
| 18022059 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME | MCCORMICK, CATHERINE LYNN | 1638 | §101DPOther | Non-Final OA | — | Pending | Feb 17, 2023 |
| 17785879 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | LEONARD, ARTHUR S | 1631 | §112Other | Non-Final OA | — | Pending | Jun 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial